Top Industry Leaders in the Metabolic Biomarker Testing Market
Latest Metabolic Biomarker Testing Companies Updates:
Thermo Fisher Scientific Acquired Personalis, Inc., a leader in next-generation sequencing (NGS) and clinical genomics, aiming to strengthen its presence in personalized medicine and expand its portfolio of metabolic biomarker testing solutions.
Roche Diagnostics Partnered with Metabolon, Inc., a leader in metabolomics research, to develop and commercialize new diagnostic tests based on metabolic biomarkers for various diseases, including metabolic disorders and certain cancers.
Agilent Technologies Collaborated with University of California, San Diego to develop novel AI-powered algorithms for analyzing and interpreting mass spectrometry data from metabolic biomarker testing, aiming to improve diagnostic accuracy and personalized treatment recommendations.
Bio-Rad Laboratories Introduced the QSight™ OMICS platform, a streamlined system for high-throughput metabolomics analysis, facilitating faster and more cost-effective metabolic biomarker testing in clinical settings
Bruker Corporation Launched the timsTOF Flex MALDI MS system, offering superior sensitivity and resolution for identifying and quantifying a wider range of metabolic biomarkers, opening doors for new diagnostic and research applications.
Danaher Corporation Developed the SCIEX TripleTOF 6600+ liquid chromatography-mass spectrometry (LC-MS) system, providing enhanced capabilities for detecting and characterizing low-abundance metabolic biomarkers, further advancing personalized medicine approaches.
List of Metabolic Biomarker Testing Key companies in the market:
- Agilent Technologies, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Bruker Corporation (U.S.)
- Danaher Corporation (U.S.)
- Waters Corporation (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Shimadzu Corporation (Japan)
- Biocrates Life Sciences AG (Austria)